Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

New guidelines help interventional cardiologists manage chronic venous disease
"These recommendations will help ensure that patient care remains both consistent and personalized," SCAI President Srihari S. Naidu, MD, explained.
Jury finds PeaceHealth, ER doctor not liable for misdiagnosing patient’s stroke
After a three week trial, a jury found that PeaceHealth and Ralph Weiche, MD, acted in accordance with medical protocols in diagnosing Patricia Parker with a psychiatric condition, given her unusual symptoms.
Women less likely to receive DCD heart transplants
Donation after circulatory death heart transplants are gaining popularity in the United States, but men are much more likely to be selected for one.
Mayo Clinic develops AI capable of substantially improving dementia diagnoses
With the software's help, readers are up to three times more accurate and interpretations are nearly twice as fast.
Private equity firm jumps into vascular health with new investment
Vascular Technology, first founded 40 years ago, is planning on using the new funds to grow and expand its portfolio.

Apple removes all vaping-related apps from its online store

Apple has opted to remove all vaping-related apps from its App Store in the midst of an e-cigarette epidemic that’s fueled more than 2,000 cases of vaping-related lung injury and at least 42 fatalities.

Gout drug colchicine makes waves as potential CV therapy

Results of the late-breaking COLCOT trial, which explored the efficacy of low-dose colchicine in reducing CV risk in heart attack patients, were a highlight of the American Heart Association’s 2019 Scientific Sessions this month in Philadelphia.

ISCHEMIA: Invasive therapy no better than meds for reducing CV events

People with severe but stable ischemic heart disease don’t benefit any more from invasive CV procedures than they do from optimal medical therapy and lifestyle changes alone, according to results from the highly anticipated ISCHEMIA trial.

FDA advisors support expanded indication for icosapent ethyl

The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee voted unanimously Nov. 14 to recommend an expanded indication for icosapent ethyl, a purified omega-3 product designed to help heart patients keep their lipid levels in check.

NIH allocates minimal funding to cardiac arrest research

Research that will be presented at the American Heart Association’s Resuscitation Science Symposium in Philadelphia this month suggests the National Institutes of Health invests far less money in cardiac arrest research than in research for other conditions, including diabetes, drug-use disorders and ischemic heart disease.

Young marijuana users face increased risk of stroke

Young people who use cannabis—especially if they’re frequent users—could face an up to threefold increased risk of stroke compared to their peers, researchers have found.

AI tool predicts HF mortality with 88% accuracy

A collaboration between physicists and cardiologists at the University of California San Diego has resulted in an AI tool that can predict heart failure patients’ life expectancy with 88% accuracy.

Taller people at greater risk for AFib

Taller people might be at an increased risk for atrial fibrillation, according to research set for presentation at the American Heart Association’s Scientific Sessions on Nov. 16.

Clinical

New guidelines help interventional cardiologists manage chronic venous disease

Jury finds PeaceHealth, ER doctor not liable for misdiagnosing patient’s stroke

Women less likely to receive DCD heart transplants

Mayo Clinic develops AI capable of substantially improving dementia diagnoses

Private equity firm jumps into vascular health with new investment